Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Perspective Therapeutics, Inc. (CATX) had Cash Flow from Financial Activities of $10.11M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.29M |
|
$-21.48M |
|
-- |
|
$0.29M |
|
$24.33M |
|
$-24.04M |
|
$2.04M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-22.00M |
|
$-21.48M |
|
$-22.00M |
|
$-24.04M |
|
$-24.08M |
|
74.23M |
|
74.23M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$195.96M |
|
$62.60M |
|
$114.77M |
|
$310.73M |
|
$12.99M |
|
$1.60M |
|
$32.05M |
|
$45.03M |
|
$265.69M |
|
$215.69M |
|
$265.69M |
|
74.26M |
|
| Cash Flow Statement Financials | |
$-41.53M |
|
$-1.30M |
|
|
Cash Flow from Financial Activities |
$10.11M |
$61.58M |
|
$28.85M |
|
$-32.73M |
|
$4.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.09 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-8289.31% |
|
-8289.31% |
|
-- |
|
-7585.86% |
|
-7408.62% |
|
$-47.22M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.29 |
|
69.83 |
|
-8.28% |
|
-10.20% |
|
-7.08% |
|
-8.23% |
|
$3.58 |
|
$-0.64 |
|
$-0.56 |
|